Gilead Sciences Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2017 | $6.51B | $3.77B | $2.70B |
| Jun 2017 | $7.14B | $4.25B | $3.07B |
| Sep 2017 | $6.51B | $3.81B | $2.72B |
| Dec 2017 | $5.95B | — | $-3.87B |
| Mar 2018 | $5.09B | $2.15B | $1.54B |
| Jun 2018 | $5.65B | $2.28B | $1.82B |
| Sep 2018 | $5.60B | $2.62B | $2.10B |
| Dec 2018 | $5.80B | — | $3.0M |
| Mar 2019 | $5.28B | $2.24B | $1.98B |
| Jun 2019 | $5.69B | $2.43B | $1.88B |
| Sep 2019 | $5.60B | $-1.47B | $-1.17B |
| Dec 2019 | $5.88B | — | $2.70B |
| Mar 2020 | $5.55B | $2.40B | $1.55B |
| Jun 2020 | $5.14B | $-2.98B | $-3.34B |
| Sep 2020 | $6.58B | $2.00B | $360.0M |
| Dec 2020 | $7.42B | — | $1.55B |
| Mar 2021 | $6.42B | $2.89B | $1.73B |
| Jun 2021 | $6.22B | $2.25B | $1.52B |
| Sep 2021 | $7.42B | $3.84B | $2.59B |
| Mar 2022 | $6.59B | $197.0M | $19.0M |
| Jun 2022 | $6.26B | $2.03B | $1.14B |
| Sep 2022 | $7.04B | $2.84B | $1.79B |
| Mar 2023 | $6.35B | $1.71B | $1.01B |
| Jun 2023 | $6.60B | $1.67B | $1.05B |
| Sep 2023 | $7.05B | $2.62B | $2.18B |
| Mar 2024 | $6.69B | $-4.32B | $-4.17B |
| Jun 2024 | $6.95B | $2.64B | $1.61B |
| Sep 2024 | $7.55B | $888.0M | $1.25B |
| Mar 2025 | $6.67B | $2.24B | $1.32B |
| Jun 2025 | $7.08B | $2.47B | $1.96B |
| Sep 2025 | $7.77B | $3.33B | $3.05B |
| Mar 2026 | $6.96B | $2.59B | $2.02B |
| Jun 2026 | $7.80B | $-10.39B | $-10.50B |